Company intelligence / Profile preview

ExCEEd Orphan Distribution

Prague, Czech Republic

Ownership: Private
Development stage: Other

Overview

ExCEEd Orphan provides full commercialization services for orphan drugs and rare disease medicines in 17 Central & Eastern European countries, covering market assessment, KOL engagement, market access, pricing/reimbursement, medical education, distribution, and pharmacovigilance.

Industry: Consulting

Partnerships

Rafa LaboratoriesProveca Pharma LtdSERB S.A.S.AveXisYour Pharma Partner Alliance

Beyond the preview

Go deeper on ExCEEd Orphan Distribution.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ExCEEd Orphan Distribution.

Explore the full profile